Versiti - Research | Michael Deininger Laboratory | Versiti Blood Research Institute
Explore our service lines

Research

Translational Research of Leukemia

Leukemia white blood cells, 3d illustration. cancer cells

The Deininger lab’s expertise focuses on translational research in leukemia, specifically the biology of myeloproliferative neoplasms and the development of molecular targeted therapies. We are especially interested in developing novel, anti-neoplastic targeted therapies in myeloid leukemia, as well as understanding the molecular mechanisms of cancer stem cell persistence and leukemia drug resistance.

Our lab orchestrates a multidisciplinary cancer research program, straddling genetics, biochemistry, molecular biology, pharmacology and biomedical engineering. We are proud of our vibrant team of scientists who strive to improve the diagnosis, deep analysis and therapeutics of myeloid leukemia.

Deininger Laboratory Research Projects

Strategies to Target BCR-ABL1 Compound Mutants

Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL

Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia

Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia

A Bioluminescent Assay for Direct Measurement of Sirtuin Activity in Cancer Cells

A Bioluminescent Assay for Direct Measurement of Sirtuin Activity in Cancer Cells

The Function of MS4A3 in Normal and Malignant Hematopoiesis

Function of MS4A3